Terra Pharma Profile
Key Indicators
- Authorised Capital ₹ 2.00 Cr
- Paid Up Capital ₹ 1.00 Cr
- Company Age 4 Year, 11 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 2.70 M
- Revenue Growth 52.60%
- Profit Growth 20.45%
- Ebitda 29.60%
- Net Worth -35.22%
- Total Assets 36.26%
About Terra Pharma
Terra Pharma Private Limited (TPPL) is a Private Limited Indian Non-Government Company incorporated in India on 18 February 2020 (Four years and 11 months 14 days old ). Its registered office is in Hyderabad, Telangana, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 2.00 Cr and a paid-up capital of Rs 1.00 Cr.
The company currently has active open charges totaling ₹2.70 M.
Revanth Nadipally and Prasanna Todupunoori serve as directors at the Company.
Company Details
-
Location
Hyderabad, Telangana, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U24304TG2020PTC139338
-
Company No.
139338
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
18 Feb 2020
-
Date of AGM
30 Sep 2023
-
Date of Balance Sheet
31 Mar 2023
-
Listing Status
Unlisted
-
ROC Code
Roc Hyderabad
Industry
Who are the key members and board of directors at Terra Pharma?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Revanth Nadipally
|
Managing Director | 18-Feb-2020 | Current |
Board Members (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
|
Prasanna Todupunoori
|
Director | 09-Sep-2020 | Current |
Financial Performance of Terra Pharma.
Terra Pharma Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 52.6% increase. The company also saw a substantial improvement in profitability, with a 20.45% increase in profit. The company's net worth observed a substantial decline by a decrease of 35.22%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Terra Pharma?
In 2023, Terra Pharma had a public holding of 58.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Kvs Medicals Private LimitedPrasanna Todupunoori is a mutual person
-
Paramitha Women & Kids Care Chintal Private Limited
Prasanna Todupunoori is a mutual person
Charges (Loans)
₹0.27 Cr
₹0
Charges Breakdown by Lending Institutions
- Hdfc Bank Limited : 0.27 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 04 Feb 2023 | Hdfc Bank Limited | ₹2.70 M | Open |
How Many Employees Work at Terra Pharma?
Unlock and access historical data on people associated with Terra Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Terra Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Terra Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
